FHIR IG analytics| Package | ig-ee-medication-scheme |
| Resource Type | ClinicalUseDefinition |
| Id | ClinicalUseDefinition-renal-function-failure.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ClinicalUseDefinition renal-function-failure
Language: et
Profile: EETISRenalFailureDS
ExtensionEETISAffectedMedicationStatements: MedicationStatement: extension = ,100,2023-11-07,,,Avalik,order,; status = recorded; category = Pidev,Tavaretsept,3-kordne; effective[x] = 2015-02-07 13:28:17-0500 --> (ongoing); note = patsient peaks iga päev veresuhkrut mõõtma
ExtensionEETISAdditionalInformationLink: www.synbase.ee/metformin-neerufunktsioon
ExtensionEETISNephrotoxic: false
ExtensionEETISDosageModification
- dosageIntervalMin: 6
- dosageIntervalMax: 12
- recommendation: Siin on soovitused
ExtensionEETISRelatedObservationOrCondition: Observation 62238-1
type: Undesirable Effect
category: Kirjeldus siia text alla, kui on veel vaja midagi lisada, Kirjeldus siia text alla, kui on veel vaja midagi lisada, Kuna vosoritiidi ohutust ja efektiivsust neerukahjustuse korral ei ole hinnatud [(1)],[(2)], ei saa tõenduspõhiseid soovitusi anda. Siiski, tuginedes eliminatsioonimehhanismile, ei mõjuta neerupuudulikkus ilmselt vosoritiidi farmakokineetikat. Vosoritiid on modifitseeritud C-tüüpi natriureetiline peptiid. Vosoritiidi metabolism toimub eeldatavasti kataboolsete radade kaudu ja laguneb väikesteks peptiidideks ja aminohapeteks [(1)], [(2)].
status: active
| Classification |
| Kui on veel vaja midagi lisada |
Generated Narrative: Medication #metformin
Language: et
Profile: EETISMedicationEPC
ExtensionEETISMedicinalProductClassification: metformiin
identifier:
http://ravimiregister.ee/pakendid/123456doseForm: tablett+õhukese polümeerikattega tablett
totalVolume: 120
ingredient
Items
Concept metformiin isActive: true
strength: 500(unit MG from https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik) (Details: retsept-mahu-ja-massiyhik codeMG = 'milligram(s)')/1(unit TABL from https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik) (Details: ER_Ühikud mahu- ja massiühikud codeTABL = 'tablet(s)')
{
"resourceType": "ClinicalUseDefinition",
"id": "renal-function-failure",
"meta": {
"profile": [
"https://fhir.ee/StructureDefinition/ee-tis-renal-failure-ds"
]
},
"language": "et",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"contained": [
{
"resourceType": "Medication",
"id": "metformin",
"meta": {
"profile": [
"https://fhir.ee/StructureDefinition/ee-tis-medication-epc"
]
},
"language": "et",
"extension": [
{
"url": "https://fhir.ee/StructureDefinition/ee-tis-medicinal-product-classification",
"valueCodeableConcept": {
"coding": [
{
"system": "https://fhir.ee/CodeSystem/atc-ee",
"code": "A10BA02",
"display": "metformiin"
}
]
}
}
],
"identifier": [
{
"system": "http://ravimiregister.ee/pakendid",
"value": "123456"
}
],
"doseForm": {
"coding": [
{
"system": "https://fhir.ee/CodeSystem/ravimvormid",
"code": "1518",
"display": "tablett+õhukese polümeerikattega tablett"
}
]
},
"totalVolume": {
"value": 120
},
"ingredient": [
{
"item": {
"concept": {
"coding": [
{
"system": "https://fhir.ee/CodeSystem/toimeained",
"code": "11354",
"display": "metformiin"
}
]
}
},
"isActive": true,
"strengthRatio": {
"numerator": {
"value": 500,
"system": "https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik",
"code": "MG"
},
"denominator": {
"value": 1,
"system": "https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik",
"code": "TABL"
}
}
}
]
}
],
"extension": [
{
"url": "https://fhir.ee/StructureDefinition/ee-tis-affected-medication-statements",
"valueReference": {
"reference": "MedicationStatement/MedicationStatement-metformin"
}
},
{
"url": "https://fhir.ee/StructureDefinition/ee-tis-additional-information-link",
"valueString": "www.synbase.ee/metformin-neerufunktsioon"
},
{
"url": "https://fhir.ee/StructureDefinition/ee-tis-nephrotoxic",
"valueBoolean": false
},
{
"extension": [
{
"url": "dosageIntervalMin",
"valueQuantity": {
"value": 6
}
},
{
"url": "dosageIntervalMax",
"valueQuantity": {
"value": 12
}
},
{
"url": "recommendation",
"valueString": "Siin on soovitused"
}
],
"url": "https://fhir.ee/StructureDefinition/ee-tis-dosage-modification"
},
{
"url": "https://fhir.ee/StructureDefinition/ee-tis-related-observation-or-condition",
"valueReference": {
"reference": "Observation/observation-egfr1"
}
}
],
"type": "undesirable-effect",
"category": [
{
"coding": [
{
"system": "https://fhir.ee/CodeSystem/drug-form-group",
"code": "2",
"display": "süsteemne"
}
],
"text": "Kirjeldus siia text alla, kui on veel vaja midagi lisada"
},
{
"coding": [
{
"system": "https://fhir.ee/CodeSystem/failure-degree",
"code": "1",
"display": "GFR 30-59 ml/min (mõõdukas neerupuudulikkus)"
}
],
"text": "Kirjeldus siia text alla, kui on veel vaja midagi lisada"
},
{
"text": "Kuna vosoritiidi ohutust ja efektiivsust neerukahjustuse korral ei ole hinnatud [(1)],[(2)], ei saa tõenduspõhiseid soovitusi anda. Siiski, tuginedes eliminatsioonimehhanismile, ei mõjuta neerupuudulikkus ilmselt vosoritiidi farmakokineetikat. Vosoritiid on modifitseeritud C-tüüpi natriureetiline peptiid. Vosoritiidi metabolism toimub eeldatavasti kataboolsete radade kaudu ja laguneb väikesteks peptiidideks ja aminohapeteks [(1)], [(2)]."
}
],
"subject": [
{
"reference": "#metformin"
}
],
"status": {
"coding": [
{
"code": "active"
}
]
},
"undesirableEffect": {
"classification": {
"coding": [
{
"system": "https://fhir.ee/synbase-warning-classification",
"code": "C",
"display": "Annust või annustamise vahemikku tuleb kohandada"
}
],
"text": "Kui on veel vaja midagi lisada"
}
}
}